[ 1 ] Graziano1 F, Arduini F, Ruzzo A, et al. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs[J]. Ann Oncol, 2004, 15(3): 489-492.
[2]
[ 2 ] Monika Z, Ferreira AM, Czopek JP, et al. CDH1 gene promoter hypermethylation in gastric cancer: relationship to Goseki grading, microsatellite instability status, and EBV invasion[J]. Diagn Mol Pathol, 2006, 15(1): 24-29.
[3]
[ 3 ] Giovanni C, Anna B, Daniele M, et al. CDH1 C-160A promoter polymorphism and gastric cancer risk[J]. Eur J Cancer Prev, 2009, 18(1): 46-49.
[4]
[ 4 ] Gen T, Jing Y, Suna W, et al. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas[J]. J Natl Cancer Inst, 2000, 92(7): 569-573.
[5]
[ 5 ] Hatakeyama M. The role of Helicobacter pylori CagA in gastric carcinogenesis[J]. Int J Hematol, 2006, 84 (4): 301-308.
[6]
[ 6 ] Costa AC, Figueiredo C, Touati E. Pathogenesis of Helicobacter pylori infection[J]. Helicobacter, 2009, 14(Suppl 1): 15-20.
[7]
[ 7 ] Lim JW, Kim H, Kim KH. Cell adhesion-related gene expression by Helicobacter pylori in gastric epithelial AGS cells[J]. Int J Biochem Cell Biol, 2003, 35(8): 1284-1296.
[8]
[ 8 ] Grabiano F, Humar B, Guilford P. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice[J]. Ann Oncol, 2003, 14(12): 1705-1713.
[9]
[ 9 ] Tamana M, Yoko M, Yasuhisa S, et al. E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold astritis[J]. Helicobacter, 2007, 12(5): 523-531.
[10]
Carvalho B, Pinto M, Cirnes L, et al. Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas[J]. Eur J Cancer, 2003, 39(9): 1222-1227.
[11]
Lee TL, Leung WK, Chan MW, et al. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma[J]. Clin Cancer Res, 2002, 8(6): 1761-1766.
[12]
Goseki N, Takizawa T, Koike M. Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma[J]. Gut, 1992, 33(5): 606-612.
[13]
Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk[J]. Clin Cancer Res, 2006, 12(3): 989-995.
[14]
Mayer B, Johnson JP, Leitl F, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration[J]. Cancer Res, 1993, 53(7): 1690-1695.
[15]
Oka H, Shiozaki H, Kobayashi K, et al. Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer[J]. Virchows Arch A Pathol Anat Histopathol, 1992, 421(2): 149-156.
[16]
Hirohashi S. Inactivation of the E-cadherin mediated cell adhesion system in human cancers[J]. Am J Pathol, 2008, 153(2): 333-339.
[17]
Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas[J]. Cancer Res, 2004, 54(14): 3845-3852.
[18]
Tamura G, Sakata K, Nishizuka S, et al. Inactivation of Ecadherin gene in primary gastric carcinomas and gastric carcinoma cell lines[J]. Jpn J Cancer Res, 2006, 87(11): 1153-1159.
[19]
Graff JR, Herman JG, Myohanen S, et al. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation[J]. J Biol Chem, 2007, 272(35): 22322-22329.
[20]
Aggerholm A, Guldberg P, Hokland M, et al. Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia[J]. Cancer Res, 2009, 59(2): 436-441.
